Sfoglia per Tipologia Article (author)
Hyperoxemic perfusion for treatment of reperfusion microvascular ischemia in patients with myocardial infarction
2003 A.L. Bartorelli
Hyperoxemic perfusion of the left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction
2006 D. Trabattoni, A.L. Bartorelli, F. Fabbiocchi, P. Montorsi, P. Ravagnani, M. Pepi, F. Celeste, A. Maltagliati, G. Marenzi, W.W. O'Neill
Hyperoxia and oxidative stress in anesthesia and critical care medicine
2020 S. Ottolenghi, G. Sabbatini, A. Brizzolari, M. Samaja, D. Chiumello
Hyperoxia in head injury : therapeutic tool?
2004 L.G. Longhi, N. Stocchetti
Hyperparathyroidism and anemia in renal failure
2000 M. Gallieni, C. Corsi, D. Brancaccio
Hyperparathyroidism and anemia in uremic subjects : a combined therapeutic approach
2004 D. Brancaccio, M. Cozzolino, M. Gallieni
Hyperparathyroidism secondary to hyperaldosteronism
2010 F. Fortina, S. Bellosta
Hyperphenylalaninemia and potential renal acid load (PRAL)
2008 D. Casero, M. Borzani, F. Sala, G. Cagnoli, E. Salvatici, S. Paci, M. Giovannini
Hyperphosphatemia : a novel risk factor for mortality in chronic kidney disease
2018 M. Cozzolino, P. Ciceri, A. Galassi
Hyperphosphatemia and vascular calcification in chronic kidney disease
2006 M. Cozzolino, D. Brancaccio
Hyperphosphatemia in dialysis patients : the therapeutic role of lanthanum carbonate
2007 M. Cozzolino, D. Brancaccio
Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib
2017 G. Bombeccari, U. Garagiola, F. Pallotti, M. Rossi, M. Porrini, A. Giannì, F. Spadari
Hyperplane sections of abelian surfaces
2012 E. Colombo, P. Frediani, G. Pareschi
Hyperplasia of the aorticopulmonary paraganglia : a new insight into the pathogenesis of sudden infant death syndrome?
1998 S.G. Ramos, L. Matturri, B. Biondo, G. Ottaviani, L. Rossi
Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene
2001 M. Bonomi, M.C. Proverbio, G. Weber, G. Chiumello, P. Beck Peccoz, L. Persani
Hyperpolarization-activated cyclic nucleotide-gated channel 1 is a molecular determinant of the cardiac pacemaker current I-f
2001 A. Moroni, L. Gorza, M. Beltrame, B. Gravante, T. Vaccari, M.E. Bianchi, C. Altomare, C. Longhi, C. Heurteaux, M. Vitadello, A. Malgaroli, D. Difrancesco
Hyperprothrombinaemia-induced APC resistance : differential influence on fibrin formation and fibrinolysis
2006 B.M. Binetti, C. Rotunno, A. Tripodi, D. Asti, F. Semeraro, N. Semeraro, M. Colucci
Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism
2004 M. Colucci, B.M. Binetti, A. Tripodi, V. Chantarangkul, N. Semeraro
Hyperprothrombinemia may result in acquired activated protein C resistance
2000 A. Tripodi, V. Chantarangkul, P.M. Mannucci
HyperReal : a modular control architecture for HRT systems
1996 F. De Paoli, F. Tisato, C. Bellettini
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile